Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

‘Light and sound’ therapy for Alzheimer’s flops in long-anticipated trial

Nature MedicineView source article

Part of story

Cognito's light-and-sound Alzheimer's headset fails pivotal trial

Cognito Therapeutics' Spectris AD device, which uses flickering light and rhythmic sound to induce gamma waves, failed to meaningfully slow Alzheimer's disease progression in its long-anticipated Phase 3 trial.

Nov 17, 2026·2 sourcesNeurodegenerative diseaseAlzheimer's diseaseAlzheimer’s & dementiaNeuroscienceFDA regulatory approvalDrug Policy, Pricing & ApprovalRandomized controlled trialClinical trials
Cognito's light-and-sound Alzheimer's headset fails pivotal trial
00

Other sources for this story

The Boston Globe

Device that uses light and sound may slow Alzheimer’s symptoms in some patients